Ajanta Pharma Limited (BOM:532331)
India · Delayed Price · Currency is INR 3,451.70
+103.10 (3.08%)
At close: Oct 28, 2026
Ajanta Pharma Market Cap
Ajanta Pharma has a market cap or net worth of 432.25 billion as of October 28, 2026. Its market cap has increased by 44.63% in one year.
Market Cap
432.25B
Enterprise Value
428.28B
Revenue
57.76B
Global Rank
n/a
Country Rank
n/a
PE Ratio
38.01
ChartMarket Cap Chart
Since April 1, 2002, Ajanta Pharma's market cap has increased from 565.80M to 432.25B, an increase of 76,297.24%. That is a compound annual growth rate of 30.99%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2026 | 432.25B | 25.00% |
| Dec 31, 2025 | 345.80B | -5.57% |
| Dec 31, 2024 | 366.20B | 39.58% |
| Dec 29, 2023 | 262.36B | 68.96% |
| Dec 30, 2022 | 155.28B | -19.73% |
| Dec 31, 2021 | 193.46B | 36.89% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Aurobindo Pharma | 943.50B |
| Glenmark Pharmaceuticals | 649.60B |
| Alkem Laboratories | 605.72B |
| Ipca Laboratories | 490.71B |
| Gland Pharma | 489.51B |
| Ajanta Pharma | 426.81B |
| Emcure Pharmaceuticals | 352.20B |
| Wockhardt | 310.39B |